Description
BIOVECTRA is a global biotech and pharmaceutical contract development and manufacturing organisation (CDMO) that specializes in clinical-to-commercial scale production capabilities for biologics, small molecules, fermented small molecules, bioreagents, plasmid DNA (pDNA), messenger RNA (mRNA), lipid nanoparticles (LNP), and fill/finish services. With more than 50 years of experience, over 640 employees, and cGMP facilities in Prince Edward Island and Nova Scotia, Canada, BIOVECTRA is committed to ensuring that its programs advance on time and with the highest quality outcomes. In 2023, the company celebrated the completion of its $90+ million biologics expansion at its new state-of-the-art Biomanufacturing Centre, focusing on mRNA, pDNA, LNP, and fill/finish work.
Services include:
- Regulatory Services
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Protein and Peptide
- Cell and Gene Therapy
- Analytical Services
- Bioanalytical Services
- Biologics
- Process Development
- Bioprocessing
- cGMP Synthesis
- Chemical Analysis
- Chromatography
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Downstream Processing
- Drug Delivery Devices
- Fermentation
- Manufacturing
- Antibody-Drug Conjugates
- Aseptic Fill-Finish
- Cytotoxic & High Potency Compounds
- Lyophilization
- Microbial-based Therapeutic Proteins
- Oligonucleotides
- Syringe, Pre-filled
- Microbial Fermentation
- Protein Extraction/Purification
- Purification
- Quality QA/QC
- Scale-Up
- Sterile Filling
- Fine Chemicals
- Technology Transfer
- Machinery & Equipment
BIOVECTRA continues to be a reliable partner in the pharmaceutical industry, providing a comprehensive range of manufacturing and development services to meet evolving market demands. For more information, visit biovectra.com.
Capabilities
- Analytical Services
- Antibody-Drug Conjugates
- APIs (Active Pharmaceutical Ingredients)
- Asceptic Fill-Finish
- Bioanalytical Services
- Biologics
- Bioprocessing
- Cell and Gene Therapy
- cGMP Synthesis
- Chemical Analysis
- Chromatography
- Containment
- Contract Development and Manufacturing (CDMO)
- Cytotoxic & High Potency Compounds
- Downstream Processing
- Drug Delivery Devices
- Fermentation
- Fine Chemicals
- Lyophilization
- Machinery & Equipment
- Microbial Fermentation
- Microbial-based Therapeutic Proteins
- Oligonucleotides
- Process Development
- Protein and Peptide
- Protein Extraction/Purification
- Purification
- Quality QA/QC
- Regulatory Services
- Scale-Up
- Sterile Filling
- Syringe
- Technology Transfer
Contact Information
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.